Cerenia Tablets are the first FDA-approved medication to prevent motion sickness-related vomiting in dogs. Cerenia anti-vomiting medications are available in scored tablets for easy administration. By blocking substance P, a compound responsible for triggering vomiting, Cerenia can prevent acute vomiting in dogs.
CERENIA™ TABLETS (maropitant citrate)
Cerenia Tablets contains maropitant citrate which acts an antiemetic. By blocking substance P, a compound responsible for triggering vomiting, Cerenia can prevent acute vomiting in dogs. Four different strengths for different sized dogs.
Prevents nausea and vomiting in dogs
Helps treat motion sickness and vomiting
DOSAGE AND ADMINISTRATION:
CERENIA Tablets are recommended for use in dogs 8 weeks and older.
Prevention of Acute Vomiting
Minimum of 2 mg/kg BW Dosing
CERENIA Tablets may be used interchangeably with CERENIA Injectable Solution for once daily dosing for
the prevention of acute vomiting.
For Prevention of Vomiting Due to Motion Sickness
Administer CERENIA Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up
to 2 consecutive days.
Dogs should be fasted 1 hour prior to administration of CERENIA Tablets. Administer CERENIA Tablets 2
hours prior to travel.
Minimum of 8 mg/kg BW Dosing
The safe use of CERENIA Tablets has not been evaluated in dogs used for breeding,
pregnant or lactating bitches, dogs with gastrointestinal obstruction, or dogs that have ingested toxins. Use with
caution in dogs with hepatic dysfunction. Use with caution with other medications that are highly protein
bound. The concomitant use of CERENIA with other protein bound drugs has not been studied in dogs.
Commonly used protein bound drugs include NSAIDs, cardiac, anticonvulsant and behavioral medications. The
influence of concomitant drugs that may inhibit metabolism of CERENIA has not been evaluated. Drug
compatibility should be monitored in patients requiring adjunctive therapy.
Not for use in humans. Keep out of reach of children. In case of accidental ingestion, seek
medical advice. Topical exposure may elicit localized allergic skin reactions in some individuals. Repeated or
prolonged exposure may lead to skin sensitization. Wash hands with soap and water after administering drug.
CERENIA is also an ocular irritant. In case of accidental eye exposure, flush with water for 15 minutes and
seek medical attention.
In puppies younger than 11 weeks of age, histological evidence of bone marrow hypoplasia was seen at higher
frequency and greater severity in puppies treated with CERENIA than in control puppies. In puppies 16 weeks
and older, bone marrow hypoplasia was not seen.
CERENIA Tablets should be stored at controlled room temperature 20°-25°C
(68°-77°F) with excursions between 15°-30°C (59°-86°F).